- Type / Class
- Equity / Common Stock
- Shares outstanding
- 13,404,566
- Total 13F shares
- 12,224,634
- Share change
- +24,701
- Total reported value
- $117,473,974
- Price per share
- $9.61
- Number of holders
- 125
- Value change
- +$236,847
- Number of buys
- 72
- Number of sells
- 42
Quarterly Holders Quick Answers
What is CUSIP 035255108?
CUSIP 035255108 identifies ANIK - Anika Therapeutics Inc - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 035255108:
Top shareholders of ANIK - Anika Therapeutics Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
6.8%
from 13D/G
|
1,741,762
|
$16,372,563 | — | 30 Sep 2025 | |
| Trigran Investments, Inc. |
13F
13D/G
|
Company |
1.2%
from 13D/G
|
1,621,215
|
$15,239,422 | — | 30 Sep 2025 | |
| Caligan Partners LP |
13F
|
Company |
11%
|
1,435,130
|
$13,490,222 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13D/G
13F
|
Company |
4.5%
|
657,355
|
$9,656,545 | $0 | 31 Dec 2024 | |
| BlackRock Portfolio Management LLC |
13D/G
|
— |
5.5%
|
793,359
|
$7,454,957 | $0 | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.8%
|
780,663
|
$7,338,232 | — | 30 Sep 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
4.7%
|
632,791
|
$5,941,000 | — | 30 Sep 2025 | |
| CAPITAL MANAGEMENT CORP /VA |
13F
|
Company |
4.1%
|
551,248
|
$5,181,727 | — | 30 Sep 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
4%
|
539,642
|
$5,072,635 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
4%
|
533,017
|
$5,010,360 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
2.9%
|
394,741
|
$3,710,565 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.5%
|
335,681
|
$3,156,398 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.4%
|
323,378
|
$3,039,753 | — | 30 Sep 2025 | |
| Michael L. Levitz |
3/4/5
|
EVP, CFO, Treasurer |
—
mixed-class rows
|
119,966
mixed-class rows
|
$1,761,044 | — | 15 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.3%
|
175,315
|
$1,647,961 | — | 30 Sep 2025 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.98%
|
130,809
|
$1,229,605 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.89%
|
119,112
|
$1,119,653 | — | 30 Sep 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.82%
|
109,814
|
$1,032,252 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.77%
|
103,870
|
$976,378 | — | 30 Sep 2025 | |
| Cove Street Capital, LLC |
13F
|
Company |
0.76%
|
101,956
|
$958,386 | — | 30 Sep 2025 | |
| GLOBEFLEX CAPITAL L P |
13F
|
Company |
0.65%
|
87,600
|
$823,440 | — | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.65%
|
86,874
|
$816,616 | — | 30 Sep 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.61%
|
81,290
|
$764,126 | — | 30 Sep 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.6%
|
79,921
|
$751,257 | — | 30 Sep 2025 | |
| Anne Nunes |
3/4/5
|
SVP, Chief Operations Officer |
—
mixed-class rows
|
65,283
mixed-class rows
|
$725,770 | — | 14 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.55%
|
73,724
|
$693,006 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.48%
|
64,975
|
$610,765 | — | 30 Sep 2025 | |
| Thomas Finnerty |
3/4/5
|
EVP, Human Resources |
—
mixed-class rows
|
29,695
mixed-class rows
|
$589,713 | — | 09 Mar 2022 | |
| Jeffery S. Thompson |
3/4/5
|
Director |
—
class O/S missing
|
31,575
|
$588,242 | — | 14 Jun 2023 | |
| Glenn R. Larsen |
3/4/5
|
Director |
0.37%
|
50,258
|
$564,899 | — | 20 Jun 2025 | |
| Susan L. N. Vogt |
3/4/5
|
Director |
0.37%
|
50,213
|
$564,394 | — | 20 Jun 2025 | |
| Quantinno Capital Management LP |
13F
|
Company |
0.44%
|
58,594
|
$550,784 | — | 30 Sep 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.43%
|
58,145
|
$546,563 | — | 30 Sep 2025 | |
| Stephen Richard |
3/4/5
|
Director |
0.36%
|
47,871
|
$538,070 | — | 20 Jun 2025 | |
| DIKER MANAGEMENT LLC |
13F
|
Company |
0.42%
|
56,839
|
$534,287 | — | 30 Sep 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.4%
|
52,994
|
$498,144 | — | 30 Sep 2025 | |
| Sheryl L. Conley |
3/4/5
|
Director |
0.32%
|
42,568
|
$478,464 | — | 20 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.37%
|
50,090
|
$470,844 | — | 30 Sep 2025 | |
| Gary P. Fischetti |
3/4/5
|
Director |
0.31%
|
41,613
|
$467,730 | — | 20 Jun 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.37%
|
49,739
|
$467,546 | — | 30 Sep 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.37%
|
49,463
|
$464,951 | — | 30 Sep 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.36%
|
47,911
|
$450,364 | — | 30 Sep 2025 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.35%
|
47,016
|
$441,950 | — | 30 Sep 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.34%
|
45,938
|
$431,817 | — | 30 Sep 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.34%
|
45,843
|
$430,924 | — | 30 Sep 2025 | |
| Trexquant Investment LP |
13F
|
Company |
0.33%
|
44,691
|
$420,095 | — | 30 Sep 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.31%
|
41,743
|
$392,000 | — | 30 Sep 2025 | |
| PharVision Advisers, LLC |
13F
|
Company |
0.31%
|
41,386
|
$389,028 | — | 30 Sep 2025 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.28%
|
37,447
|
$352,002 | — | 30 Sep 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.28%
|
36,883
|
$346,700 | — | 30 Sep 2025 |
Institutional Holders of Anika Therapeutics Inc - Common Stock (ANIK) as of Q4 2025
As of 31 Dec 2025,
Anika Therapeutics Inc - Common Stock (ANIK) was held by
125 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,224,634 shares.
The largest 10 holders included
BlackRock, Inc., Caligan Partners LP, VANGUARD GROUP INC, MORGAN STANLEY, ACADIAN ASSET MANAGEMENT LLC, BOOTHBAY FUND MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, CAPITAL MANAGEMENT CORP /VA, DIMENSIONAL FUND ADVISORS LP, and STATE STREET CORP.
This page lists
125
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
114
Q4 2025 holders
125
Holder diff
11
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.